Hikma Buys Injectables Specialist Custopharm In $400m+ Deal

Deal To Acquire California-Based Firm Will Bolster Hikma’s US Injectables Business

Injectables Vials Syringe
Hikma has agreed a $400m+ deal for sterile injectables specialist Custopharm • Source: Alamy

More from Deals

More from Business